From: COVID-19 related deaths in an urban academic medical center in Brooklyn – a descriptive case series
Pharmacotherapy treatment for COVID-19 (n, %) | |
Hydroxychloroquinea | 134 (67) |
Full dose anticoagulationa | 11 (5·5) |
Tocilizumaba | 10 (5) |
Steroidsa | 10 (5) |
Time to treatment with hydroxychloroquine, median (IQR), hours | 16 (6–39·75) |